Phenylacetamides as anti-allergy, anti-asthma and anti-inflammat

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514563, 560 40, 562445, A61K 3124, A61K 31195, C07C10104

Patent

active

045798664

ABSTRACT:
Compounds of the structure ##STR1## and pharmaceutically acceptable salts thereof, wherein: R.sub.1 and R.sub.2 are independently H, OH, lower alkyl, lower alkoxy, aryloxy, heteroaryloxy, heteroaryl lower alkoxy, aryl, heteroaryl, aryl-lower alkyl, aryl-lower alkoxy, halogenated aryl-lower alkoxy, lower alkenyl, lower alkynyl, lower alkenoxy, lower alkynoxy, halogen or trifluoromethyl;

REFERENCES:
patent: 3586713 (1971-06-01), Buu-Hoi et al.
Gilbert et al., Chemical Abstracts, vol. 85, No. 122759e, (1976).
Obrecht et al., Chemical Abstracts, vol. 95, No. 62673s, (1981).
Viel et al., Chemical Abstracts, vol. 65, No. 13651h, 1966.
Belsten et al., Chemical Abstracts, vol. 60, No. 7992a, 1964.
Kupchan et al., Chemical Abstracts, vol. 66, No. 38094j, 1967.
Bottcher et al., Chemical Abstracts, vol. 44, No. 8334g, 1950.
Starmer et al., Chemical Abstracts, vol. 75, No. 47094x, 1971.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenylacetamides as anti-allergy, anti-asthma and anti-inflammat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenylacetamides as anti-allergy, anti-asthma and anti-inflammat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenylacetamides as anti-allergy, anti-asthma and anti-inflammat will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1084713

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.